Market Value6,612,776,360
Total Holdings72
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PEN / Penumbra, Inc.
GMED / Globus Medical, Inc.
XNCR / Xencor, Inc.
IMVT / Immunovant, Inc.
RNA / Avidity Biosciences, Inc.
MRUS / Merus N.V.
PEPG / PepGen Inc.
CBLL / CeriBell, Inc.
URGN / UroGen Pharma Ltd.
AKRO / Akero Therapeutics, Inc.
TEM / Tempus AI, Inc.
NGNE / Neurogene Inc.
GERN / Geron Corporation
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
STOK / Stoke Therapeutics, Inc.
TXG / 10x Genomics, Inc.
SABS / SAB Biotherapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
ARTV / Artiva Biotherapeutics, Inc.
CRVS / Corvus Pharmaceuticals, Inc.
CGON / CG Oncology, Inc.
ALKS / Alkermes plc
REPL / Replimune Group, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
IMUX / Immunic, Inc.
SAGE / Sage Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
SLRN / Acelyrin, Inc.
IDYA / IDEAYA Biosciences, Inc.
TRML / Tourmaline Bio, Inc.
ALUR / Allurion Technologies Inc.
BRKR / Bruker Corporation
RGNX / REGENXBIO Inc.
ROIV / Roivant Sciences Ltd.
EPIX / ESSA Pharma Inc.
GKOS / Glaukos Corporation
BIOA / BioAge Labs, Inc.
AXSM / Axsome Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
GHRS / GH Research PLC
ARGX / argenx SE - Depositary Receipt (Common Stock)
RARE / Ultragenyx Pharmaceutical Inc.
PTGX / Protagonist Therapeutics, Inc.
NTRA / Natera, Inc.
QURE / uniQure N.V.
CGEM / Cullinan Therapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
ORKA / Oruka Therapeutics, Inc.
ADGM / Adagio Medical Holdings, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
WVE / Wave Life Sciences Ltd.
LENZ / LENZ Therapeutics, Inc.
INSM / Insmed Incorporated
PCSC / Perceptive Capital Solutions Corp
SYRE / Spyre Therapeutics, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
ARVN / Arvinas, Inc.
CYTK / Cytokinetics, Incorporated
TSHA / Taysha Gene Therapies, Inc.
IMTX / Immatics N.V.
ACAD / ACADIA Pharmaceuticals Inc.
MASI / Masimo Corporation
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
RDNT / RadNet, Inc.
DYN / Dyne Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
XGN / Exagen Inc.
CRGX / CARGO Therapeutics, Inc.
ETNB / 89bio, Inc.
OBIO / Orchestra BioMed Holdings, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ESTA / Establishment Labs Holdings Inc.
PTCT / PTC Therapeutics, Inc.
SYK / Stryker Corporation
MIST / Milestone Pharmaceuticals Inc.